Platelet Rich Plasma (PRP) Injection for Lateral Epicondylitis (Tennis Elbow)

Phase-Based Progress Estimates
Lateral Epicondylitis (Tennis Elbow)+1 More
Platelet Rich Plasma (PRP) Injection - Other
All Sexes
What conditions do you have?

Study Summary

This trial will compare four different treatments for tennis elbow: platelet rich plasma, whole blood, dry needle tendon fenestration, and sham injection (with physical therapy).

Eligible Conditions
  • Lateral Epicondylitis (Tennis Elbow)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Baseline, 6 weeks, 3, 6, 12, 24 months

Month 12
Pain Reduction
Month 24
Functional Disability
Health-Related Quality of Life
Psychological Impairment

Trial Safety

Trial Design

4 Treatment Groups

Whole Blood Injection
1 of 4
Dry Needle Fenestration
1 of 4
Platelet Rich Plasma (PRP) Injection
1 of 4
Sham Injection
1 of 4
Active Control
Experimental Treatment
Non-Treatment Group

100 Total Participants · 4 Treatment Groups

Primary Treatment: Platelet Rich Plasma (PRP) Injection · Has Placebo Group · N/A

Platelet Rich Plasma (PRP) Injection
Experimental Group · 1 Intervention: Platelet Rich Plasma (PRP) Injection · Intervention Types: Other
Whole Blood Injection
ActiveComparator Group · 1 Intervention: Whole Blood Injection · Intervention Types: Other
Sham Injection
PlaceboComparator Group · 1 Intervention: Sham Injection · Intervention Types: Other
Dry Needle Fenestration
ActiveComparator Group · 1 Intervention: Dry Needle Fenestration · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 6 weeks, 3, 6, 12, 24 months

Who is running the clinical trial?

Arthrex, Inc.Industry Sponsor
40 Previous Clinical Trials
19,217 Total Patients Enrolled
The Physicians' Services Incorporated FoundationOTHER
155 Previous Clinical Trials
24,801 Total Patients Enrolled
Radiological Society of North AmericaOTHER
21 Previous Clinical Trials
4,709 Total Patients Enrolled
McMaster UniversityLead Sponsor
791 Previous Clinical Trials
1,456,193 Total Patients Enrolled
Mary M Chiavaras, MD, PhDPrincipal InvestigatorMcMaster University

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 25th, 2021

Last Reviewed: October 13th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.